Markers were sought to identify the antenatal starting times and rates at which brain damage advanced in children with hypoxemic-ischemic cerebral palsy.
INTRODUCTION
Electronic fetal heart rate monitoring has long been used to identify the risk and thereby prevent brain damage in children caused by antenatal hypoxemia-ischemia. Multiple studies have reported that the monitoring does not reduce the brain damage's frequency. [1] [2] [3] If other opportunities to prevent the damage exist, how might they be found? First, new tools would be needed that can routinely identify what caused the hypoxemia-ischemia, when its damage began, the rate at which the damage advanced and when it ended. Identifying what caused the hypoxemia-ischemia is usually possible by integrating information from clinical, laboratory and placental findings. Identifying the brain damage's time of onset, its rate of advance and when it ended requires new tools. Multiple such timers are needed so that cross-checks of their findings can routinely be performed. The present studies searched for such timer-tools. Studies were also undertaken to determine why the brain damage often continues after birth with the hope that this information might point the way to its prevention.
MATERIALS AND METHODS
Clinical, laboratory, brain image and placental findings were reviewed from 608 pregnancies that had produced full-term neonates with cerebral palsy of possible antenatal, hypoxemic-ischemic origin. A few of the children had mainly motor impairments. Most had cognitive disabilities as well. The medical records from these pregnancies along with slides having placental tissues for microscopic review came from parties in malpractice claims, our medical center's medical records, treating physicians at other institutions and parents who wanted explanations for their child's cerebral palsy. The clinical, laboratory, ECG, brain imaging and placental information available for many of these children served as the database for the studies. The research protocols for the studies were approved by our medical center's Institutional Review Board.
First, children with nonhypoxemic-ischemic causes of their brain damage were excluded from the database to be analyzed. Exclusion criteria were: (a) children growth retarded to <10th percentile for body weight, height or head circumference at birth, (b) children with recognized malformations, (c) children with a known genetic disorder. Medical records were then screened for children who had electronic fetal heart rate monitoring (EFM) documentation of the sudden, unexpected onset of fetal bradycardia (<70 beats/minute) that continued for 20 or more minutes until birth. To be included in the study, children also had to be single born at >37 weeks of gestation and have no other evidence of fetal stress prior to the bradycardia's onset. A total of 92 children met these criteria and were therefore included in the studies. Except for blood gas findings most of the 92 did not have complete enough data sets to be included in every subsequent analysis.
In primate studies the onset of fetal bradycardia has closely coincided with the start of hypoxemic-ischemic brain damage. 4, 5 On this basis the present studies used bradycardia's onset time as the baseline to determine if other clinical, laboratory and brain image findings had value as timers of the brain damage's start. Neonates whose antenatal bradycardia was r15 minutes in duration were not included in the analyses because hypoxemiaischemia of this short duration rarely produces brain damage. Children who might have experienced earlier hypoxemia before birth because of some recognized chronic placental, fetal or maternal disorder were excluded from the analyses.
Serial blood counts from birth of the children's lymphocytes, normoblasts and platelets were analyzed first (Figures 1-3 ). These analyses are based on multiple counts in individual children, usually more than three during the first 5 hours after birth. A previous study with fewer children than the present study found that lymphocyte counts increased to >10,000/mm 3 at birth after Z25 minutes of acute onset fetal bradycardia initiated by hypoxemia-ischemia. 6 These counts decreased to subnormal numbers at predictable times after birth. The present study repeated these earlier studies, using a threshold count of 9500/mm 3 within an hour of birth to identify lymphocytosis. Analyses were also conducted to determine the postnatal durations of these elevated lymphocyte counts for fetal bradycardia durations of <60, 60 to 120 and >120 minutes (Figure 1 ). The three groups contained 40, 10 and eight children.
Normoblast counts in the blood of neonates were analyzed as a second possible timer of the brain damage's onset (Figure 2 ). The counts were converted to the percent of their first count recorded within 8 hours of birth. The counts were not analyzed when neonates were hypoxemic (arterial blood PO 2 values <60 mmHg) for longer than 0.5 hours after birth.
Serial platelet counts were next analyzed in neonates as potential timers of the damaging hypoxemia-ischemia's antenatal onset because an earlier study found that such counts began a progressive decrease 20 to 24 hours after the hypoxemic-ischemic damage had begun ( Figure 3 ). 6 If a neonate's first count was normal, analyses of subsequent platelet counts were converted to the percent of the child's first count recorded within 2 hours of birth.
A total of 22 of the children had recorded base excess values from both umbilical arterial and umbilical venous bloods drawn at birth. Negative values reflect the presence of metabolic acids produced in fetal organs by hypoxemia-ischemia. These acids are initially absorbed within the placenta with resulting less negative base excess values in umbilical venous than in umbilical arterial blood. If the hypoxemia-ischemia continues long enough, the placental absorption sites for these acids become saturated and base excess values equalize in the two bloods. If this equalization occurs at a predictable time after damaging hypoxemia-ischemia begins, comparing the values in the two bloods can reveal if the antenatal duration of the hypoxemia-ischemia was longer or shorter than this equalization time. Both values were recorded in the medical records of 29 neonates in the present study (Figure 4) . The 29 were normotensive after their births, so neonatal hypotension should not have slowed the escape of metabolic acids from their damaged organs into their blood.
Serial tests of neonates' heart, liver and kidney functions were analyzed to determine if evidences of their dysfunction appeared after a predictable duration of antenatal bradycardia and presumed damaging hypoxemia-ischemia. An earlier smaller study found that this bradycardia duration damage time was 25 to 30 minutes for all three organs. 6 Mean arterial blood pressures <35 mmHg that persisted for >0.5 hours after birth were used as evidence of cardiovascular dysfunction in neonates. Renal dysfunction was deemed present when neonates had hematuria, a serum creatinine value >1.5 mg/dl, or a BUN value >20 mg/dl on two or more days after birth. Liver dysfunction was identified by a serum aspartate transaminase value of >60 IU/l or a serum alanine transaminase level >50 IU/l during the week after birth.
All 92 term born neonates in the study had arterial blood PCO 2 and PO 2 values recorded during the first 2 hours after their birth. Almost all were mechanically ventilated rather than spontaneously hyperventilating due to in utero acidosis. In all, 35 of the 92 were hyperventilated to arterial blood PCO 2 values r25 mmHg at least once during this 2 hour period. Such hypocapnia has been shown to cause severe cerebral vasoconstriction with resulting brain damage in preterm born neonates. [7] [8] [9] An analysis was undertaken to determine if such damage had taken place in any of the 35 term born neonates of the present study. To make this determination, the antenatal durations of the 35 children's bradycardia were charted against the postbirth patterns of their brain damage ( Figure 5 ). Controls were the 17 neonates who were more normally ventilated as reflected by arterial blood PCO 2 values >25 mmHg during their first 2 hours after their birth.
Finally, it has been postulated that very high oxygen levels in a neonate's blood just after birth can also cause brain injury by severely reducing cerebral blood flow. [8] [9] [10] This claim was explored by dividing the 82 neonates who had both arterial blood PO 2 and PCO 2 values recorded within 0.6 hours following their birth into four categories based on their oxygenation and ventilation values during that period ( Table 1 ). The first group of 39 were hyperventilated to arterial blood PCO 2 levels r25 mmHg and PO 2 levels Z150 mmHg. The second group of 16 were also Brain damage progressed at a much more rapid rate in the 34 neonates who were hyperventilated to arterial blood PCO 2 values <25 mm Hg during the first hour after their birth than neonatals not so hyperventilated.
hyperventilated but had more normal PO 2 values, that is, <150 mmHg. The third group of 11 had normal PCO 2 values and elevated PO 2 values (<150 mmHg.). The fourth group had normal arterial blood PCO 2 (>25 mmHg) and PO 2 values (<150 mmHg). The effects of these differing neonatal managements were determined by the proportion of neonates in each category who had cortical gray matter in addition to white matter brain damage in brain images obtained after 6 months of age (Table 1 ). All evaluations of brain damage were based on two or more interpretations of MRI brain images by neuroradiologists, at least one of which was taken after 1 month of age.
Statistical Analysis
Lymphocyte counts and the duration of antenatal bradycardia were rescaled using a logarithmic transformation to obtain an approximately linear relationship. A random coefficients model was used for the regression of lymphocyte counts on duration to account for multiple lymphocyte counts per neonate. 11 Neither the random intercept nor slope terms were significant, so they were dropped from the model. Parametric survival regression analyses were used to model separately the relationships between the time that unremitting bradycardia began and changes in normoblast and platelet counts. 12 Median survival time was defined as the time required for half of the neonates in the group under study to reach the requisite percent of the first count. Data from individual neonates were censored at the time of the last count if their counts had never decreased. Observations were interval censored, as only the interval during which counts decreased to a specified level was known.
RESULTS
All six timers had a prebirth time frame within which specific damage onset times could be identified. Blood lymphocyte counts were <9500 cell/mm 3 when antenatal bradycardia had lasted r25 minutes (Figure 1 ). When bradycardia was 26 to 59 minutes in duration, lymphocyte counts were >9500 cell/mm 3 for a mean postnatal duration of 4.4 hours (95% CI: 3.5 to 5.4 hours). Some of the neonates had multiple lymphocyte counts performed during the 4 to 6 hours period after their birth, others less frequent counts. When the bradycardia had lasted 1 to 2 hours, the mean duration of lymphocyte counts >9500 cells/mm 3 was 6.8 hours (95% CI: 4.9 to 9.3 hours). When bradycardia exceeded 2 hours, the mean duration was 13.7 hours (95% CI: 9.6 to 19.5 hours).
When antenatal bradycardia had exceeded 25 minutes, neonates' blood normoblast counts were markedly elevated (Figure 2 ). When the hypoxemia was promptly relieved after birth, the median time for normoblast counts to drop 20% was 11.0 hours (95% CI: 8.6 to 14.2 hours), to drop 50% was 14.8 hours (CI: 10.8 to 20.4 hours), and to drop 80%, 22.7 hours (95% CI: 17.0 to 30.4 hours).
When heart, liver and kidney dysfunction accompanied a neonate's brain damage, the child's platelet counts decreased from normal values after birth (Figure 3 ). This decrease was presumably the consequence of toxic products from the damaged visceral organs entering children's blood and initiating intravascular coagulation. When all three organs dysfunctioned, the median time after bradycardia's onset for platelet counts to decrease 15% was 13.9 hours (95% CI: 10.2 to 18.8 hours), to decrease 30% was 27.3 hours (95% CI: 20.8 to 35.8) and to decrease 50% was 57.6 hours (95% CI: 43.8 to 75.7 hours).
A total of 29 of the neonates had recorded base excess values from both umbilical arterial and umbilical venous bloods drawn at birth. Initially, the metabolic acids in their umbilical arterial blood produced by the hypoxemia-ischemia were absorbed in their placentas with resultant less negative base excess values in their umbilical venous than in their umbilical arterial blood. After 40 minutes of bradycardia, placental absorption sites for these acids were saturated and base excess values equalized in the two bloods (Figure 4) .
Both the duration of prebirth bradycardia and how neonates were ventilated just after birth affected the severity of their brain damage. When neonates' arterial blood PCO 2 values were consistently >25 mmHg, the damage began in basal ganglia, spread to white matter and then to gray matter after 40 minutes of bradycardia ( Figure 5 ). These times markedly shortened when neonates had been hyperventilated to arterial blood PCO 2 values <25 mmHg during the first 40 minutes after birth. The neonates so hyperventilated had severe white and gray matter brain damage after as little as 10 to 12 minutes of such hyperventilation ( Figure 5 ).
To determine if hyperoxygenating neonates can independently initiate brain damage, 54 neonates in the present study were studied who had been hyperoxygenated to arterial blood PO 2 values Z150 mmHg during the first half hour after their birth (Table 1) . Since many of these neonates were also hyperventilated, there is a need to distinguish between these two effects. This was done by using the new timers of the brain damage's onset to identify additional 84 term born children with antenatal/neonatal hypoxemic-ischemic brain damage that had originated within an hour before birth and could have been potentiated by hyperventilation, hyperoxemia or both after birth. Both hyperoxemia and hyperventilation appear to have independently greatly accelerated the brain damage's progression (Table 1) . Indicators of neonates' heart, liver and kidney dysfunction also correlated with the durations of their antenatal hypoxemiaischemia. None of the 10 neonates born following <24 minutes of fetal bradycardia were hypotensive or had evidences of kidney or liver dysfunction after birth. Such multiple organ dysfunction was present and persisted for hours to several days after birth in 75% of the children with longer durations of antenatal bradycardia. How did the remaining 25% escape multiorgan injury? The hypoxemia-ischemia in their cases had been caused by either fluctuating umbilical cord compression or by meconium-initiated vasoconstriction in their placentas. 13 Umbilical cord compression can fluctuate with changing fetal movements. Meconium in the amniotic fluid is only occasionally toxic as evidenced by necrosis and severe dysplasia in amnion cells on the surface of the placenta. 13 Over time it enters the chorionic plate of the placenta where its toxic properties induce progressive vasoconstriction. 13 It is postulated that with both umbilical cord compression and toxic meconium enough blood flow sometimes continues or is intermittently present to prevent multiorgan damage.
SIGNIFICANCE
The present studies used the onset of fetal bradycardia to identify the start of hypoxemic-ischemic antenatal brain damage in 52 children. Using this baseline, six tools were discovered that in combination could identify when their brain damage began and the rate at which it advanced both before and after birth. Having these tools in hand for routine use is key to determining how much of the damage might eventually be prevented or its progression slowed. For example, what might electronic fetal heart rate monitoring currently be accomplishing? Could it be preventing brain damage in some children and preserving the lives of others who are now damaged but would have died without the interventions it initiated?
A second use of the timers could be to identify in detail the timing and specific circumstances surrounding the brain damage caused by hyperventilating and hyperoxygenating neonates. The present studies found evidence that both rapidly accelerate the neonatal progression of this damage. The acceleration produced by hyperventilation was first documented in preterm born infants by Greisen et al. 7 in 1987. Since that time it has been confirmed in neonates by multiple other investigators. 8, 9 The risks of damaging neonates' brain by hyperoxygenation has been more recently recognized. 10 Perhaps the new timing tools can better identify the specific circumstances during which hyperventilation and hyperoxygenation damage neonates' brains. The tools should always be able to document that hypoxemic-ischemic brain damage had already taken place when gravidas entered an obstetrical facility to deliver.
To apply all these new findings, umbilical arterial and venous bloods need to be collected at birth for pH, PCO 2 , PO 2 , bicarbonate, and base excess value determinations. This is also the optimal time to collect a neonate's blood for baseline counts of lymphocytes, normoblasts and platelets. Entering these values onto the charts developed during the present studies will reveal when subsequent tests need to be performed. Clinical and laboratory evidences of heart, liver and kidney function also need to be documented because evidences of their malfunction characteristically appear after 25 or more minutes of damaging antenatal hypoxemia-ischemia.
Finally, there are circumstances in which the new timers cannot identify when antenatal hypoxemic-ischemic brain damage began and the rate at which it advanced. Among these are settings in which a fetus or neonate experienced a large blood loss or a disorder independently slowed the production or shortened the lifespans of the timer cells. It also remains to be determined which of the tests developed in the study can be applied at various preterm gestational ages. Finally, it remains to be determined if information derived from the tests might have value in interpreting the results of interventions designed to prevent the brain damage.
